Truxima (rituximab-abbs) is an FDA-approved biosimilar to Rituxan (Rituximab) used to treat adults with Rheumatoid Arthritis (RA) with another prescription medicine called methotrexate, to reduce the signs and symptoms of moderate to severe active RA, after treatment with at least one other medicine called a tumor necrosis factor (TNF) antagonist has been used and did not work well enough. It is also use to treat adults with Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA): with glucocorticoids.
Truxima is administered intravenously. One course of treatment includes 2 infusions given 2 weeks apart. Infusions generally take 4 to 6 hours. Truxima is typically administered every 6 months, or based on your doctor’s evaluation of your symptoms. If your symptoms return before it’s time for your next course, you and your physician may decide to treat earlier (but no sooner than 4 months).
Your doctor should check you for Hepatitis B before starting Truxima.
Your doctor may give you certain medicines before infusions to help reduce side effects such as acetaminophen and/or diphenhydramine HCI.
Number of yearly treatments: 4
Before you attend your first appointment at Sage Infusion, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices, Patient Rights and Responsibilities, and Appointment Lateness and Cancelation are for reference only. Please contact us if you have any questions!
Find a Sage Infusion Location Near You
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
SEARCH BY ZIP